ACADIAN ASSET MANAGEMENT LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 81 filers reported holding RECRO PHARMA INC in Q2 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2022$12,000
-81.0%
15,584
-56.1%
0.00%
Q1 2022$63,000
-58.8%
35,536
-60.6%
0.00%
-100.0%
Q4 2021$153,000
-44.4%
90,219
-32.6%
0.00%0.0%
Q3 2021$275,000
-51.1%
133,773
-45.0%
0.00%
-50.0%
Q2 2021$562,000
-37.4%
243,199
-24.5%
0.00%
-33.3%
Q1 2021$898,000
-29.3%
321,964
-27.8%
0.00%
-40.0%
Q4 2020$1,270,000
+51.0%
445,702
+11.2%
0.01%
+25.0%
Q3 2020$841,000
-37.3%
400,645
+36.0%
0.00%
-33.3%
Q2 2020$1,341,000
-33.9%
294,551
+18.6%
0.01%
-50.0%
Q1 2020$2,030,000
-51.2%
248,340
+9.4%
0.01%
-36.8%
Q4 2019$4,160,000
+63.1%
227,011
-1.4%
0.02%
+72.7%
Q3 2019$2,551,000
-3.0%
230,254
-11.0%
0.01%
-15.4%
Q2 2019$2,631,000
+84.1%
258,740
+6.1%
0.01%
+116.7%
Q1 2019$1,429,000
-26.6%
243,782
-11.2%
0.01%
-40.0%
Q4 2018$1,948,000
-5.6%
274,456
-5.4%
0.01%
+11.1%
Q3 2018$2,063,000
+83.4%
290,124
+29.5%
0.01%
+80.0%
Q2 2018$1,125,000
+117.2%
224,062
+376.2%
0.01%
+150.0%
Q1 2018$518,000
+1892.3%
47,049
+1153.3%
0.00%
Q2 2017$26,000
-82.7%
3,754
-78.1%
0.00%
-100.0%
Q1 2017$150,000
+7.1%
17,136
+8.6%
0.00%0.0%
Q3 2016$140,00015,7740.00%
Other shareholders
RECRO PHARMA INC shareholders Q2 2018
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders